Evidence mapPaperPMID 41491851Full record

ArticleDiabetology & metabolic syndrome2026

Lipid metabolism-inflammation crosstalk and risk of incident cancer, cardiovascular diseases, and stroke among individuals with prediabetes: findings from a nationwide, population based, prospective cohort study.

Wenjie Li, Jian Chen, Yiming Fu, Wei Wang, Qin Zeng

Abstract read
In one paragraph

Article in Diabetology & metabolic syndrome, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wenjie Li *Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.ORCID http://orcid.org/0000-0001-5285-8939
Jian Chen *Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Yiming FuThe First School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, Guangdong, China. yimingfu_gd@163.com.
Wei WangDepartment of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. wwei9500@smu.edu.cn.
Qin ZengDepartment of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. 16613673@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrediabetes is a well-established risk factor for cardiovascular diseases (CVD), stroke, and cancer, but whether this risk is uniform across all individuals remains uncertain. Additionally, heterogeneity within the prediabetic population, driven by mechanisms like lipid metabolism dysfunction and inflammation, has not been fully explored.

methodsThis study analyzed data from 3,065 prediabetic participants (mean age: 58.8 ± 9.7, 53.8% women) from the China Health and Retirement Longitudinal Study. We used generalized linear models, Cox regression, and subgroup analyses to evaluate the risk of progression to CVD, stroke, and cancer. To delineate distinct subgroups among individuals with prediabetes, we devised a stratification framework predicated on the coexistence of dyslipidemia, the triglyceride-glucose (TyG) index, and the C-reactive protein-triglyceride glucose (CTI) index.

resultsPrediabetic participants were classified into four subgroups: metabolically sensitive, inflammation-driven, metabolic lipotoxicity, and systemic metabolic-inflammatory (a subtype defined by concurrent dyslipidemia and elevated CTI values indicating combined metabolic and inflammatory dysregulation). Compared with the metabolically sensitive subtype, the inflammation-driven, metabolic lipotoxicity, and systemic metabolic-inflammatory subtypes exhibited significantly heightened risks of cancer, CVD, and stroke, even after adjustment for confounding variables (all p < 0.05). Furthermore, dose-response analyses revealed a robust linear association between increasing levels of CTI, low-density lipoprotein cholesterol, and TyG index and the incidence of cancer, CVD, and stroke.

conclusionsPrediabetic individuals with inflammation and/or lipid metabolism dysregulation are at a markedly higher risk of developing CVD, stroke, and cancer. Tailored prevention and intervention strategies are necessary to address the distinct risk profiles within the prediabetic population.

Indexed as

Cardiovascular diseasesInflammationLipid metabolismPrediabetesStroke

Identifiers

PMID41491851
PMCPMC12870519

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.